Klivira
Request demo

Automating AdvancedMD Trulicity Prior Authorization Workflows

Klivira streamlines AdvancedMD Trulicity prior authorization, ensuring efficient data extraction and submission directly from your ambulatory EHR. This integration accelerates patient access to critical GLP-1 therapies by automating complex PA requirements.

For revenue cycle directors and prior authorization coordinators utilizing AdvancedMD, managing GLP-1 agonist PAs like Trulicity presents unique challenges. The need for precise clinical documentation and navigating pharmacy benefit versus medical benefit PAs can significantly impact operational efficiency and patient care timelines. Klivira addresses these bottlenecks by integrating directly with AdvancedMD to automate the entire prior authorization process for dulaglutide.

Navigating Trulicity Prior Authorization within AdvancedMD

Trulicity (dulaglutide) orders, common for type 2 diabetes management, frequently trigger prior authorization requirements due to its GLP-1 agonist classification and payer step-therapy protocols. Within AdvancedMD, this often initiates a manual workflow involving chart review, documentation gathering, and potential routing to specialty pharmacies. Klivira's integration automates the identification and initiation of these PAs directly from the AdvancedMD order entry, reducing manual burden.

Klivira's Integration with AdvancedMD for Trulicity PAs

Klivira leverages the AdvancedMD API to establish a robust connection, enabling automated extraction of necessary patient and clinical data for Trulicity prior authorizations. This direct integration eliminates manual data entry into payer portals or separate ePA systems, significantly reducing staff time and potential for human error. The system intelligently collates all required information to build a comprehensive PA request package.

Pharmacy vs. Medical Benefit: Trulicity in AdvancedMD

As a self-administered injectable GLP-1 agonist, Trulicity typically falls under the pharmacy benefit. Klivira's platform understands how AdvancedMD's system differentiates between these benefit types and ensures the correct ePA pathway is utilized. Whether requiring an X12 278 for medical benefit PAs or NCPDP SCRIPT for pharmacy benefit, Klivira automatically routes the request to the appropriate channel, ensuring compliance with payer requirements.

Optimizing Documentation for Trulicity Prior Authorization

Payer criteria for Trulicity PAs often require specific clinical documentation. Klivira's integration pulls key data points directly from AdvancedMD's clinical notes and problem lists, including diagnosis codes for type 2 diabetes, current A1C levels, evidence of failed oral agents, BMI, and relevant comorbidities. This ensures that all necessary information to demonstrate medical necessity is accurately compiled and submitted, improving approval rates.

Streamlining Specialty Pharmacy Coordination

Many GLP-1 agonists like Trulicity are dispensed through specialty pharmacies. Klivira's automation extends beyond PA submission, facilitating seamless communication post-approval. The platform ensures that approved prior authorization details and prescription information are accurately and promptly transmitted to the designated specialty pharmacy, minimizing delays in medication fulfillment and improving overall patient access.

Frequently asked questions

How does Klivira identify Trulicity PA requirements in AdvancedMD?

Klivira's integration monitors order entry within AdvancedMD. Upon identification of Trulicity (dulaglutide) orders, particularly for type 2 diabetes, the system automatically flags the need for prior authorization based on configured payer rules and the drug's GLP-1 class status.

What clinical data does Klivira extract from AdvancedMD for Trulicity PAs?

Klivira leverages the AdvancedMD API to pull critical clinical data. This includes patient demographics, diagnosis codes for type 2 diabetes, A1C levels, documentation of failed oral agents, BMI, and relevant comorbidity information from the problem list and clinical notes, all essential for payer medical necessity criteria.

Does Klivira differentiate between pharmacy and medical benefit PAs for GLP-1s in AdvancedMD?

Yes, Klivira's platform is designed to recognize that Trulicity, as a self-administered injectable, typically falls under the pharmacy benefit. The system automatically initiates the appropriate ePA transaction, whether X12 278 for medical benefit or NCPDP SCRIPT for pharmacy benefit, ensuring compliance with payer requirements.

How does Klivira support specialty pharmacy routing for Trulicity orders originating in AdvancedMD?

Once a Trulicity prior authorization is approved, Klivira facilitates the seamless transfer of necessary information to the designated specialty pharmacy. This integration ensures that the approved PA and prescription details are communicated efficiently, minimizing delays in medication fulfillment for the patient.

What impact does Klivira have on denial rates for Trulicity PAs within AdvancedMD?

By ensuring comprehensive data submission and adherence to payer-specific clinical criteria, Klivira's automation aims to reduce preventable denials. The system helps ensure all required documentation, such as proof of step therapy or A1C thresholds, is present before submission, improving first-pass approval rates.

Related coverage

Other advancedmd prior auth coverage

Ready to automate prior auth for this integration?

See how Klivira automates prior authorizations for your team.

Request a demo